Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (002399)
Market Open
10 Aug, 06:57
XSHE XSHE Primary ¥
10. 96
+1
+10.0402%
¥
17.58B Market Cap
- P/E Ratio
1% Div Yield
13.59M Volume
- Eps
¥ 9.96
Previous Close Want to track 002399 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (002399) Statistics
Valuation metrics
Market Cap 17.58B
Enterprise value 13.42B
Trailing P/E (ttm) 38.34
Forward P/E -
PEG ratio -0.91
Price/Sales (ttm) 2.29
Price/Book (mrq) 1.2
Enterprise Value/Revenue 2.48
Enterprise Value/EBITDA 13.28
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 4.58M
Average volume (90 days) 5.16M
Price summary
52-Week low 8.5
52-Week high 13.61
Beta -
50-Day moving average 9.53
200-Day moving average 10.64
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate 0.14
Trailing annual dividend yield 0.0146%
5-Year annual dividend yield -
Payout ratio 0.12
Dividend Date 18 Jun 2026
Ex-Dividend Date 18 Jun 2026
Last split factor 16:10
Last split Date 13 Jun 2016
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin 0.07%
Operating margin 0.12%
Operational effectiveness
Return on assets 0.02%
Return on equity 0.03%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 3.69
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 0.26
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 2.39
Total debt (mrq) -
Total Debt/Equity (mrq) 0.23
Current ratio (mrq) 2.15%
Book value per share (mrq) 8.33
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
